Correlation Between Elevation Oncology and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Elevation Oncology and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Cardio Diagnostics.
Diversification Opportunities for Elevation Oncology and Cardio Diagnostics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Elevation and Cardio is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Elevation Oncology and Cardio Diagnostics
Given the investment horizon of 90 days Elevation Oncology is expected to generate 5.13 times less return on investment than Cardio Diagnostics. But when comparing it to its historical volatility, Elevation Oncology is 1.52 times less risky than Cardio Diagnostics. It trades about 0.01 of its potential returns per unit of risk. Cardio Diagnostics Holdings is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 112.00 in Cardio Diagnostics Holdings on October 4, 2024 and sell it today you would lose (27.00) from holding Cardio Diagnostics Holdings or give up 24.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Elevation Oncology vs. Cardio Diagnostics Holdings
Performance |
Timeline |
Elevation Oncology |
Cardio Diagnostics |
Elevation Oncology and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Elevation Oncology and Cardio Diagnostics
The main advantage of trading using opposite Elevation Oncology and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |